Erudio Healtherudio.com
Clinical trial · no report yet · Phase not applicable
YCT trial: what clinicians have said so far
The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
- NCT05121558 ↗
- Active, not recruiting
- Dana-Farber Cancer Institute
- Focused size, estimated: 1–150 verified statements
We haven't built an HCP commentary report on YCT (chemotherapy-induced peripheral neuropathy; tests a strategy, not a drug) yet. This page shows the registry record and the public commentary we found that names the trial. A report reads that commentary and sets out what clinicians said about the trial, each point linked to its source. How reports are made.
Indexed commentary on YCT so far
Podcasts, YouTube videos and X posts we have indexed that name the trial. It is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.
| Indexed so far | |
|---|---|
| 3 posts on X | |
| 1 YouTube video |
The trial
ClinicalTrials.gov- Official title
- A Randomized Phase III Clinical Trial of Yoga for Chemotherapy-induced Peripheral Neuropathy Treatment (YCT)
- Phase
- Phase not applicable
- Status
- Active, not recruiting
- Conditions
- Chemotherapy-induced Peripheral Neuropathy; Nerve Pain; Neuropathy; Neuropathy, Painful; Pain; CIPN - Chemotherapy-Induced Peripheral Neuropathy; Chronic Pain
- Interventions
- Yoga; Education control; Usual care
- Arms
- Yoga · Experimental
- Education control (EC) · Experimental
- Usual care (UC) · Active comparator
- Enrollment
- 227
- Primary outcomes
- measuring Chemotherapy-Induced Peripheral Neuropathy pain severity after Yoga
- Sponsor
- Dana-Farber Cancer Institute with National Cancer Institute (NCI)
- Start
- Oct 29, 2021
- Primary completion
- Sep 30, 2028 (estimated)
- Results posted
- No
- Registry record
- NCT05121558 · updated Sep 22, 2026